FCE
Fiera Capital (Europe) Portfolio holdings
AUM $213M
1-Year Return
42.4%
This Quarter Return
+3.78%
1 Year Return
+42.4%
3 Year Return
+41.22%
5 Year Return
–
10 Year Return
–
AUM
$178M
AUM Growth
+$8.81M
(+5.2%)
Cap. Flow
+$3.13M
Cap. Flow
% of AUM
1.76%
Top 10 Holdings %
Top 10 Hldgs %
76.99%
Holding
56
New
35
Increased
9
Reduced
7
Closed
5
Top Buys
| 1 |
Vale
VALE
|
+$18.8M |
| 2 |
Ambev
ABEV
|
+$9.91M |
| 3 |
MBT
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
|
+$9.81M |
| 4 |
BRF SA
BRFS
|
+$3.09M |
| 5 |
Compañía de Cervecerías Unidas
CCU
|
+$2.05M |
Top Sells
| 1 |
BNC
CEA Industries
BNC
|
+$24.8M |
| 2 |
ABV
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
|
+$10.4M |
| 3 |
Baidu
BIDU
|
+$4.15M |
| 4 |
CBD
Companhia Brasileira de Distribuicao
CBD
|
+$2.58M |
| 5 |
VEON
VEON
|
+$2.19M |
Sector Composition
| 1 | Financials | 23.48% |
| 2 | Consumer Staples | 22.48% |
| 3 | Communication Services | 20.79% |
| 4 | Materials | 10.79% |
| 5 | Energy | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AbbVie
ABBV
$382B
| $199K | 0.11% |
+3,763
| New | +$199K |
|
27
Amgen
AMGN
$147B
| $157K | 0.09% |
+1,380
| New | +$157K |
|
28
Sanofi
SNY
$114B
| $144K | 0.08% |
+2,700
| New | +$144K |
|
29
Bristol-Myers Squibb
BMY
$94.3B
| $143K | 0.08% |
+2,700
| New | +$143K |
|
30
Biogen
BIIB
$21.1B
| $122K | 0.07% |
+436
| New | +$122K |
|
|
AGN
31
DELISTED
ALLERGAN INC
AGN
| $109K | 0.06% |
+976
| New | +$109K |
|
32
Illumina
ILMN
$15.6B
| $105K | 0.06% |
+979
| New | +$105K |
|
|
CELG
33
DELISTED
Celgene Corp
CELG
| $95K | 0.05% |
+1,126
| New | +$95K |
|
34
Medtronic
MDT
$121B
| $94K | 0.05% |
+1,641
| New | +$94K |
|
35
Innoviva
INVA
$1.22B
| $90K | 0.05% |
+3,146
| New | +$90K |
|
36
Regeneron Pharmaceuticals
REGN
$60.9B
| $90K | 0.05% |
+325
| New | +$90K |
|
37
Baxter International
BAX
$12.3B
| $78K | 0.04% |
+2,064
| New | +$78K |
|
|
FRX
38
DELISTED
FOREST LABORATORIES INC
FRX
| $67K | 0.04% |
+1,112
| New | +$67K |
|
39
Abbott
ABT
$231B
| $64K | 0.04% |
+1,673
| New | +$64K |
|
40
Viatris
VTRS
$11.1B
| $63K | 0.04% |
+1,451
| New | +$63K |
|
|
SPPI
41
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $38K | 0.02% |
+4,300
| New | +$38K |
|
42
IQVIA
IQV
$31.8B
| $35K | 0.02% |
+746
| New | +$35K |
|
43
Boston Scientific
BSX
$147B
| $33K | 0.02% |
+2,761
| New | +$33K |
|
|
SLXP
44
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $33K | 0.02% |
+370
| New | +$33K |
|
|
CVD
45
DELISTED
COVANCE INC.
CVD
| $33K | 0.02% |
+375
| New | +$33K |
|
|
CBST
46
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $33K | 0.02% |
+477
| New | +$33K |
|
47
Waters Corp
WAT
$18B
| $32K | 0.02% |
+315
| New | +$32K |
|
|
MDVN
48
DELISTED
MEDIVATION, INC.
MDVN
| $32K | 0.02% |
+1,002
| New | +$32K |
|
49
BioMarin Pharmaceuticals
BMRN
$10.4B
| $31K | 0.02% |
+446
| New | +$31K |
|
|
LIFE
50
DELISTED
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
| $31K | 0.02% |
+414
| New | +$31K |
|